Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes.
联合使用 EZH2 和 Bcl-2 抑制剂作为基因定义的 DLBCL 亚型的精准治疗
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2020002580
Scholze Hanna, Stephenson Regan E, Reynolds Raymond, Shah Shivem, Puri Rishi, Butler Scott D, Trujillo-Alonso Vicenta, Teater Matthew R, van Besien Herman, Gibbs-Curtis Destini, Ueno Hideki, Parvin Salma, Letai Anthony, Mathew Susan, Singh Ankur, Cesarman Ethel, Melnick Ari, Giulino-Roth Lisa
